In this episode of The UroGist, a podcast for urologists, by urologists, host Dr. Mike Louie of UroGen is joined by Dr. Sandip Prasad, Director of Genitourinary Surgical Oncology, Vice-Chair of Urology at Morristown Medical Center/Atlantic Health System, and principal investigator of the ENVISION clinical trial, to discuss recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) and the pivotal phase 3 ENVISION clinical trial. Dr. Prasad shares insights from the study, the burden of recurrence for patients, and what a new treatment option may mean for patients. This interview was recorded in 2024. ClinicalTrials.gov - The ENVISION Study Full Prescribing Information, Instructions for Pharmacy, Instructions for Administration, and Patient Package Insert  Important Safety Information For users listening from their desktop device, please click on the link below to access clickable show notes.  

Ver todos los episodios